aklief 50 mikrogram/g kräm
galderma nordic ab - trifaroten - kräm - 50 mikrogram/g - etanol, vattenfri hjälpämne; propylenglykol hjälpämne; trifaroten 50 mikrog aktiv substans
importal ex-lax 10 g oralt pulver i dospåse
aziende chimiche riunite angelini francesco a.c.r.a.f. s.p.a. - laktitolmonohydrat - oralt pulver i dospåse - 10 g - laktitolmonohydrat 10 g aktiv substans - laktitol
importal ex-lax 10 g oralt pulver i dospåse
orifarm ab - laktitolmonohydrat - oralt pulver i dospåse - 10 g - laktitolmonohydrat 10 g aktiv substans - laktitol
importal ex-lax 10 g oralt pulver i dospåse
orifarm ab - laktitolmonohydrat - oralt pulver i dospåse - 10 g - laktitolmonohydrat 10 g aktiv substans - laktitol
importal ex-lax 667 mg/ml oral lösning
novartis sverige ab - laktitolmonohydrat - oral lösning - 667 mg/ml - laktitolmonohydrat 667 mg aktiv substans; bensoesyra hjälpämne - laktitol
virbagen omega
virbac s.a. - rekombinant omega-interferon av felint ursprung - immunstimulatorer, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. hos katter infekterade av fiv var mortaliteten låg (5%) och påverkades inte av behandlingen.
midodrin evolan 2,5 mg tablett
evolan pharma ab - midodrinhydroklorid - tablett - 2,5 mg - midodrinhydroklorid 2,5 mg aktiv substans
midodrin evolan 5 mg tablett
evolan pharma ab - midodrinhydroklorid - tablett - 5 mg - midodrinhydroklorid 5 mg aktiv substans
tanvacare 160 mg filmdragerad tablett
2care4 aps - valsartan - filmdragerad tablett - 160 mg - valsartan 160 mg aktiv substans; laktosmonohydrat hjälpämne
tanvacare 160 mg filmdragerad tablett
2care4 aps - valsartan - filmdragerad tablett - 160 mg - valsartan 160 mg aktiv substans; laktosmonohydrat hjälpämne